The verified answer
As of Aug 2026, DEPLOY verifies Auris Health: 1 model, 7 active incidents. 1 source back the record.
Auris Health holds 1 FDA 510(k) clearance, per the DEPLOY registry.
See all 1 filingsCategorySurgical robots
Overview
American surgical robotics company developing the Monarch Platform for robotic-assisted bronchoscopy. Founded by Frederic Moll (also founder of Intuitive Surgical). Acquired by Johnson & Johnson for $3.4B in 2019, now part of J&J MedTech.
Verified record
- Verified deployments
- None on file
- Active incidents
- 7 incidents on file
Valuation of record
Company-claimedAcquisitionAcquired by Johnson & Johnson
Key facts
Founder
HQ
Founded
Acquisition
Product
FDA clearance
Monarch Quest
Incidents
Data & sources
News coverage
1
1 source backing this record.View all →
Models (1)
View all models →Auris Health on the deployment map
View the global mapAuris Health has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.
No verified deployments for Auris Health on the DEPLOY record yet. Track Auris Health to know the moment the first one is verified.
Founders (1)
- Frederic Mollsoleno longer at company
Former / Previously (2)
- Frederic Moll FounderSEC-verified
- Fred Moll Co-founder & CEOsecondary-verified
Safety record
5 recalls and 2 incidents on record (6 serious, 1 moderate). Most recent: May 2026.
Most recent: May 2026
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Incidents affecting Auris Health (7)
Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Recent coverage
Auris Health in third-party press
Johnson & Johnson MedTech Announces Clearance of MONARCH Quest for Enhanced Robotic-Assisted Bronchoscopy
J&J to enter the robotic surgery market with .4B Auris Health buy
J&J picks up robotic surgery maven Auris Health, and founder Fred Moll himself, for $3.4 billion
Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
Financial state
- Reporting basis
- aggregator_estimate
- Lifecycle stage
- acquired
- Counterparty risk class
- moderate
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Regulatory filings (1)
- fda_510kfda 510k · us_fdacleared2018-01-01
Linked models: Monarch Platform
Acquisitions (1)
- acquired by Johnson & Johnsonfull acquisition
Patent litigations (1)
- 1:18-cv-01359district_courtsettled · settled undisclosedas respondent2023-01-01
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJun 24, 2026
Added to the verified registry
- Incident recordedMay 8, 2026
Auris Monarch bronchoscope: Navigation EM error at the docking station, scope removed...
- Incident recordedApr 30, 2026
Auris Monarch: patient developed pneumothorax post-procedure requiring chest-tube...
- Incident recordedJan 21, 2026
Auris Health (J&J) recalls Monarch over unanticipated robotic arm positioning toward...
- Incident recordedOct 18, 2025
Auris Health (J&J) recalls Monarch bronchoscopes over out-of-range leak-test results
Sources (1)
Common questions
What is Auris Health?
What does Auris Health make?
Is Auris Health publicly traded?
Who competes with Auris Health?
Who is the CEO of Auris Health?
How can I invest in Auris Health?
Where is Auris Health headquartered?
Who owns Auris Health?
Where does Auris Health operate robots?
Is Auris Health a top robotics company?
When was Auris Health founded?
Are there any incidents involving Auris Health?
Is Auris Health safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-05
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-05
Sources by quality tier
- 1
- secondary-industry-publication
- Industry publication
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Auris Health.Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
In the press
Recent coverage mentioning Auris Health from third-party publications. Automatically surfaced; not part of the verified registry record.
Johnson & Johnson MedTech Announces Clearance of MONARCH Quest for Enhanced Robotic-Assisted Bronchoscopy
J&J received FDA clearance for the MONARCH Quest platform for enhanced robotic-assisted bronchoscopy, expanding its robotic surgery portfolio.
J&J to enter the robotic surgery market with .4B Auris Health buy
Johnson & Johnson acquired Auris Health for .4B, entering the robotic surgery market with the Monarch Platform for bronchoscopy.
J&J picks up robotic surgery maven Auris Health, and founder Fred Moll himself, for $3.4 billion
Johnson & Johnson acquired Auris Health for $3.4B, gaining the Monarch Platform and founder Frederic Moll, who also founded Intuitive Surgical.
Monarch is a new platform from surgical robot pioneer Frederic Moll
Auris Health unveiled the Monarch Platform, a flexible robotically-assisted bronchoscopy system, from founder Frederic Moll who previously founded Intuitive Surgical.
Machine-readable surfaces
- Markdown mirror: /companies/auris-health.md
- RSS feed: /companies/auris-health/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/df69ac5c-53c1-4fa6-94d2-8f377e9bf87c
- Revision history: /companies/auris-health/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
Video
A tutorial of the new Auris Monarch® bronchoscopy system! This revolutionary platform uses a hand-held device for better accuracy and precision when diagnosing
Franciscan Health Cancer Center Indianapolis is the first hospital in Indiana to use the Auris Monarch Robotic Bronchoscopy Platform that takes a biopsy small a
A leader in robotic surgery, Fred Moll, Co-founder & CEO of Auris Health speaks with Anthony Lacavera about how the next-generation of flexible robotics can mak
Matthew Stritt, MD, introduces Auris Health's MonarchTM platform. The robotic bronchoscopy tool is the first of its type in Nebraska and will aid in lung cancer
Reality vs attention
Auris Health draws attention at the 23rd percentile but verifies reality at the insufficient-data level among surgical robots.
6-month trend
Analysis
Limited public funding data for capital position assessment.
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Aug 18, 2026